Allen S. Melemed - Feb 1, 2024 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Stock symbol
CMRX
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 06:28 PM
Previous filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock Award $0 +28.1K +48.24% $0.00 86.4K Feb 1, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +169K $0.00 169K Feb 1, 2024 Common Stock 169K $0.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 7,031 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 7,031 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 7,031 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 7,032 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2 Includes 10,418 shares acquired under the Issuer's Employee Stock Purchase Plan on March 10, 2023.
F3 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.